Follow
Chiara Zurla
Chiara Zurla
Verified email at bme.gatech.edu
Title
Cited by
Cited by
Year
Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy
SN Byrareddy, J Arthos, C Cicala, F Villinger, KT Ortiz, D Little, N Sidell, ...
Science 354 (6309), 197-202, 2016
2512016
Computing in mammalian cells with nucleic acid strand exchange
B Groves, YJ Chen, C Zurla, S Pochekailov, JL Kirschman, PJ Santangelo, ...
Nature nanotechnology 11 (3), 287-294, 2016
2092016
Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS
AW Lifland, J Jung, E Alonas, C Zurla, JE Crowe Jr, PJ Santangelo
Journal of virology 86 (15), 8245-8258, 2012
1982012
Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy–treated macaques
PJ Santangelo, KA Rogers, C Zurla, EL Blanchard, S Gumber, K Strait, ...
Nature methods 12 (5), 427-432, 2015
1732015
Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents
EL Blanchard, D Vanover, SS Bawage, PM Tiwari, L Rotolo, J Beyersdorf, ...
Nature biotechnology 39 (6), 717-726, 2021
1502021
Visualization of early events in mRNA vaccine delivery in non-human primates via PET–CT and near-infrared imaging
KE Lindsay, SM Bhosle, C Zurla, J Beyersdorf, KA Rogers, D Vanover, ...
Nature Biomedical Engineering 3 (5), 371-380, 2019
1462019
Tethered particle motion as a diagnostic of DNA tether length
PC Nelson, C Zurla, D Brogioli, JF Beausang, L Finzi, D Dunlap
The Journal of Physical Chemistry B 110 (34), 17260-17267, 2006
1422006
Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
PM Tiwari, D Vanover, KE Lindsay, SS Bawage, JL Kirschman, S Bhosle, ...
Nature communications 9 (1), 3999, 2018
1142018
Mild innate immune activation overrides efficient nanoparticle‐mediated RNA delivery
MP Lokugamage, Z Gan, C Zurla, J Levin, FZ Islam, S Kalathoor, M Sato, ...
Advanced materials 32 (1), 1904905, 2020
902020
Characterizing exogenous mRNA delivery, trafficking, cytoplasmic release and RNA–protein correlations at the level of single cells
JL Kirschman, S Bhosle, D Vanover, EL Blanchard, KH Loomis, C Zurla, ...
Nucleic acids research 45 (12), e113-e113, 2017
702017
DNA looping kinetics analyzed using diffusive hidden Markov model
JF Beausang, C Zurla, C Manzo, D Dunlap, L Finzi, PC Nelson
Biophysical journal 92 (8), L64-L66, 2007
602007
Multilevel autoregulation of λ repressor protein CI by DNA looping in vitro
D Lewis, P Le, C Zurla, L Finzi, S Adhya
Proceedings of the National Academy of Sciences 108 (36), 14807-14812, 2011
582011
Quantifying RNA–protein interactions in situ using modified-MTRIPs and proximity ligation
J Jung, AW Lifland, C Zurla, EJ Alonas, PJ Santangelo
Nucleic acids research 41 (1), e12-e12, 2013
552013
Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung
L Rotolo, D Vanover, NC Bruno, HE Peck, C Zurla, J Murray, RK Noel, ...
Nature materials 22 (3), 369-379, 2023
542023
Characterizing mRNA interactions with RNA granules during translation initiation inhibition
C Zurla, AW Lifland, PJ Santangelo
PLoS One 6 (5), e19727, 2011
502011
Early treatment of SIV+ macaques with an α4β7 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection
PJ Santangelo, C Cicala, SN Byrareddy, KT Ortiz, D Little, KE Lindsay, ...
Mucosal immunology 11 (3), 932-946, 2018
462018
Novel tethered particle motion analysis of CI protein-mediated DNA looping in the regulation of bacteriophage lambda
C Zurla, A Franzini, G Galli, DD Dunlap, DEA Lewis, S Adhya, L Finzi
Journal of Physics: Condensed Matter 18 (14), S225, 2006
452006
Enhanced tethered-particle motion analysis reveals viscous effects
S Kumar, C Manzo, C Zurla, S Ucuncuoglu, L Finzi, D Dunlap
Biophysical journal 106 (2), 399-409, 2014
442014
Elementary simulation of tethered Brownian motion
JF Beausang, C Zurla, L Finzi, L Sullivan, PC Nelson
American Journal of Physics 75 (6), 520-523, 2007
432007
Aerosol delivery of synthetic mRNA to vaginal mucosa leads to durable expression of broadly neutralizing antibodies against HIV
KE Lindsay, D Vanover, M Thoresen, H King, P Xiao, P Badial, M Araínga, ...
Molecular Therapy 28 (3), 805-819, 2020
402020
The system can't perform the operation now. Try again later.
Articles 1–20